About Celadon Management Advisers and Consultants Customers History
Software - ProbeITY - GenoTyper - ImmunoFIT Patent Contract Services Product Applications Research

History

Celadon was founded in 1999 by Raymond J. Peterson, the Company's Chairman and Chief Scientific Officer. Dr. Peterson, a population geneticist who had been an award-winning researcher at the National Cancer Institute, realized early that the nascent genomic revolution brought with it the need for simple, powerful, commercial-quality software – the absence of which hindered increasingly high-throughput experimentation.

Establishing the Company at the University of Maryland's Technology Advancement Program incubator in College Park, Maryland, Dr. Peterson was joined in 2000 by Lawrence Kessner, a lawyer and entrepreneur who had led startup efforts in broadcast and electronic media.

Celadon's three major software platforms have been developed in conjunction with and under contract to large U.S. federal agencies – the National Cancer Institute, the U.S. Air Force, and the Centers for Disease Control and Prevention. Celadon's flagship product – the ProbeITy™ genomic assay design and ordering platform – started to take its current form in the late 1990s but has been greatly enhanced over the last decade through development work done for the NCI and several commercial customers; the Company has developed Celadon ProbeITy™ into multi-product, multiplex, Cloud-based software for nucleic acid primer and probe design; applied to personalized medicine and pathogen detection. Also in conjunction with the NCI, Celadon generated comprehensive design rules for Locked Nucleic Acids (LNA) for cancer research, diagnostics and therapy. Modified™).

For the US Air Force, Celadon developed automated clinical interpretation of FDA-approved blood test for detection of tuberculosis infection, but this product, called (Celadon ImmunoFIT, is applicable to all immunoassays. The company's third major software platform, Celadon GenoTyper, was developed under a subcontract for the CDC, and is for genotyping. All three software platform were developed under the auspices of the federal SBIR (Small Business Innovation Research) program, which permits the contractor to retain all intellectual property and proprietary rights to the developed products.

Celadon has focused primarily on developing the highest-quality, enterprise-grade software possible, through collaboration with its government and commercial customers.